A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Public ClinicalTrials.gov record NCT04204616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).
Study identification
- NCT ID
- NCT04204616
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2021 (Actual)
- Primary completion
- Oct 26, 2026 (Estimated)
- Completion
- Oct 26, 2026 (Estimated)
- Last update posted
- Nov 12, 2025
2021 – 2026
United States locations
- U.S. sites
- 57
- U.S. states
- 24
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site | Birmingham | Alabama | 35233 | — |
| Galderma Investigational Site | Birmingham | Alabama | 35244 | — |
| Galderma Investigational Site | Fountain Valley | California | 92708 | — |
| Galderma Investigational Site | Los Angeles | California | 90045 | — |
| Galderma Investigational Site | San Diego | California | 92123 | — |
| Galderma Investigational Site | San Diego | California | 92130 | — |
| Galderma Investigational Site | Santa Monica | California | 94404 | — |
| Galderma Investigational Site | Washington D.C. | District of Columbia | 20037 | — |
| Galderma Investigational Site | Aventura | Florida | 33180 | — |
| Galderma Investigational Site | Delray Beach | Florida | 33484 | — |
| Galderma Investigational Site | Hollywood | Florida | 33021 | — |
| Galderma Investigational Site | Largo | Florida | 33770 | — |
| Galderma Investigational Site | Miami | Florida | 33125 | — |
| Galderma Investigational Site | Miami | Florida | 33136 | — |
| Galderma Investigational Site | North Miami Beach | Florida | 33162 | — |
| Galderma Investigational Site | Ormond Beach | Florida | 32174 | — |
| Galderma Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Galderma Investigational Site | Tampa | Florida | 33607 | — |
| Galderma Investigational Galderma Investigational Site | Columbus | Georgia | 31904 | — |
| Galderma Investigational Site | Macon | Georgia | 31217 | — |
| Galderma Investigational Site | Newnan | Georgia | 30263 | — |
| Galderma Investigational Site | Chicago | Illinois | 60602 | — |
| Galderma Investigational Galderma Investigational Site | Chicago | Illinois | 60613 | — |
| Galderma I Galderma Investigational Site | Lake Bluff | Illinois | 60044 | — |
| Galderma Investigational Site | Indianapolis | Indiana | 46250 | — |
| Galderma Investigational Site | Topeka | Kansas | 66614 | — |
| Galderma Investigational Site | Louisville | Kentucky | 40241 | — |
| Galderma Investigational Site | Baltimore | Maryland | 21231 | — |
| Galderma Investigational Site | Boston | Massachusetts | 02111 | — |
| Galderma Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Galderma Investigational Site | Saint Joseph | Michigan | 49085 | — |
| Galderma Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Galderma Investigational Site | St Louis | Missouri | 63110 | — |
| Galderma Investigational Site | Henderson | Nevada | 89052 | — |
| Galderma Investigational Site | New York | New York | 10021 | — |
| Galderma Investigational Galderma Investigational Site | New York | New York | 10065 | — |
| Galderma Investigational Site | High Point | North Carolina | 27262 | — |
| Galderma Investigational Site | Raleigh | North Carolina | 27617 | — |
| Galderma Investigational Site | Winston-Salem | North Carolina | 27104 | — |
| Galderma Investigational Site | Cincinnati | Ohio | 45627 | — |
| Galderma Investigational Site | Cleveland | Ohio | 44106 | — |
| Galderma Investigational Site | Dublin | Ohio | 43016 | — |
| Galderma Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational Site | Anderson | South Carolina | 29621 | — |
| Galderma Investigational Site | Knoxville | Tennessee | 37909 | — |
| Galderma Investigational Site | Murfreesboro | Tennessee | 37130 | — |
| Galderma Investigational Galderma Investigational Site | Austin | Texas | 78738 | — |
| Galderma Investigational Site | Dallas | Texas | 75230 | — |
| Galderma Investigational Site | Dripping Springs | Texas | 78620 | — |
| Galderma Investigational Site | Houston | Texas | 77401 | — |
| Galderma Investigational Site | Pflugerville | Texas | 78660 | — |
| Galderma Investigational Site | Webster | Texas | 77004 | — |
| Galderma Investigational Site | Salt Lake City | Utah | 84117 | — |
| Galderma Investigational Galderma Investigational Site | Springville | Utah | 84663 | — |
| Galderma Investigational Site | Fairfax | Virginia | 22031 | — |
| Galderma Investigational Site | Lynchburg | Virginia | 24501 | — |
| Galderma Investigational Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04204616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2025 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04204616 live on ClinicalTrials.gov.